Navigation Links
Surveyed U.S. and European Neurologists Agree that a Therapy's Effect on Physical Disability is the Most Important Attribute Influencing Prescribing Decisions in Secondary-Progressive Multiple Sclerosis
Date:3/20/2013

BURLINGTON, Mass., March 20, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. and European neurologists agree that a therapy's effect on physical disability is the most influential attribute when making prescribing decisions for secondary-progressive multiple sclerosis (SP-MS)*. These same neurologists cite a therapy's effect on quality of life as the second-most important attribute, ahead of an effect on relapses, imaging metrics and other functional domains.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36784LOGO)

Current management of SP-MS relies on the use of mainline disease-modifying therapies (which include interferon-betas and Teva's Copaxone), most of which are approved broadly for the treatment of relapsing forms of MS. This category encompasses relapsing-remitting MS (RR-MS) and SP-MS patients who continue to experience relapses. Interviewed thought leaders suggest that, based on data in RR-MS, Genzyme/Sanofi/Bayer HealthCare's Lemtrada may offer advantages over sales-leading Copaxone on measures of physical disability—potentially translating into clinical benefits for SP-MS patients. 

"The neurologists we surveyed indicate that an improved effect on physical disability is one of the greatest unmet needs in SP-MS," said Decision Resources Analyst Georgiana L. Kuhlmann , S.M. "Drawing on clinical data from RR-MS trials, interviewed thought leaders indicate that Lemtrada has demonstrated the potential to partially fulfill this unmet need."

According to the DecisionBase 2013 report entitled On What Attributes Will Neurologists and Payers Differentiate Novel Therapies for Secondary-Pro
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. According to Surveyed Oncologists in the EU5, Zytiga Has Heavily Penetrated Second-Line Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC) and is Displacing Jevtana to Later-Line mCRPC
2. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
3. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
4. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
5. Blood Disorders: European Hematologists Gather in Amsterdam, June 14-17, 2012
6. Mylan Launches Generic Lipitor® in Five European Countries
7. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
8. Bristol-Myers Squibb to Present New Data on ORENCIA(R)? (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress
9. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
10. Study Results of Novocures NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
11. Cardiac Dimensions® Announces Publication of TITAN Clinical Trial Data in European Journal of Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015 ... Interactive Customer Experience Association recognized 15 winners in ... mobile, as applied across multiple vertical markets. ... Healthcare Deployment Award for its success with ... ContextMedia:Health, the leading provider ...
(Date:7/28/2015)... July 28, 2015  For many medical institutions and ... and other inventors can be a constant challenge. Taking ... and successes are rare. A new company ... that. Medical Device Investments (MDI) was created ... hospitals and physicians. MDI develops, manufactures and markets the ...
(Date:7/28/2015)... , July 28, 2015 Transparency ... report, titled " Cancer Diagnostics Market - Global ... 2020 " . According to this report, the global ... of 7.6% during the forecast period of 2014 to 2020. ... US$100,994.5 million and is expected to be worth US$168,649.3 million ...
Breaking Medicine Technology:ContextMedia:Health Receives Top Award at the ICX Association Excellence Awards 2Medical Device Investments To Become Center Of Excellence For The Commercialization Of Innovative Medical Technologies 2Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 2Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 3Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 4
... NEW YORK, April 5, 2011 Reportlinker.com announces that ... catalogue: World Biological Drugs Market 2011-2021 ... you want to find market prospects for products and ... shows you biopharma revenue forecasts for 2011 to 2021. ...
... April 5, 2011 Boston Scientific Corporation (NYSE: ... enrollment in the SuperNOVA clinical trial, an international, prospective, ... the INNOVA™ Self-Expanding Bare-Metal Stent System in patients with ... popliteal artery (PPA).  Enrollment is planned for up to ...
Cached Medicine Technology:Reportlinker Adds World Biological Drugs Market 2011-2021 2Reportlinker Adds World Biological Drugs Market 2011-2021 3Reportlinker Adds World Biological Drugs Market 2011-2021 4Reportlinker Adds World Biological Drugs Market 2011-2021 5Reportlinker Adds World Biological Drugs Market 2011-2021 6Reportlinker Adds World Biological Drugs Market 2011-2021 7Reportlinker Adds World Biological Drugs Market 2011-2021 8Reportlinker Adds World Biological Drugs Market 2011-2021 9Reportlinker Adds World Biological Drugs Market 2011-2021 10Reportlinker Adds World Biological Drugs Market 2011-2021 11Reportlinker Adds World Biological Drugs Market 2011-2021 12Boston Scientific Begins International Clinical Trial Enrollment for INNOVA™ Self-Expanding Bare-Metal Stent System 2Boston Scientific Begins International Clinical Trial Enrollment for INNOVA™ Self-Expanding Bare-Metal Stent System 3Boston Scientific Begins International Clinical Trial Enrollment for INNOVA™ Self-Expanding Bare-Metal Stent System 4
(Date:7/29/2015)... ... July 29, 2015 , ... TransFlip is an all new dynamic transition ... presets for FCPX, these transitions are easy to apply and modify for any skill-level ... With over 60 preset styles, kinetic flipping panel animations are just a few clicks ...
(Date:7/29/2015)... Arizona (PRWEB) , ... July 29, 2015 , ... ... dorms. The project, which will by the end will cost the 501(c) organization nearly ... of Arizona’s recent anti-ligature requirements. , “We took it down to the studs,” ...
(Date:7/29/2015)... MN (PRWEB) , ... July 29, 2015 , ... ... announces that it has entered into a partnership with 247Ergo, an ergonomics specialty ... health and wellness. Ergonomics projects that the companies undertake could improve worker mobility, ...
(Date:7/29/2015)... ... July 29, 2015 , ... Elizabeth Callahan, M.D., founder and ... chosen by the manufacturer to offer and perform Kybella™ under-chin ... treat and eliminate double chin fat,” Dr. Callahan explained. “Previously this area could ...
(Date:7/29/2015)... ... July 29, 2015 , ... ITW Dynatec, along with ... role, Powers is responsible for driving growth and innovation across ITW Dynatec’s worldwide ... record as an effective leader within the ITW community speaks for itself. We ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Releases FCPX Transition TransFlip for FCPX 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 3Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 2Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 3Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 2Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 3Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 2Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 3
... a new social networking Web site, at the APTA Combined ... physical therapy continuing education courses (contact hours and CEUs), for ... ... PA (PRWEB) March 23, 2009 -- F.A. Davis is pleased ...
... INSTITUTES OF HEALTH WE CAN! EDUCATION PROGRAM TO HELP KIDS AND ... the National Institutes of Health (NIH) announced today a partnership in ... ays to E nhance C hildren,s A ctivity ... at a National PEP ( P lay More, E at ...
... 23 Nickolas Hooks of Charleston, SC, will ... March 31, 2009 to meet with congressional leaders and ... more research toward a cure for epilepsy.Hooks, 15, is ... participating in Kids Speak Up! , a national ...
... MUNDELEIN, Ill., March 23 ACell, Inc. ... has signed an exclusive marketing and distribution agreement for ... will manufacture and Medline will market and distribute the ... occurring bioscaffold derived from porcine tissue. When MatriStem ...
... Virgil McArthur of Phoenix, AZ, will travel ... 31, 2009 to meet with congressional leaders and gain ... research toward a cure for epilepsy.McArthur, 15, is one ... in Kids Speak Up! , a national program ...
... Many people of East Asian descent possess an enzyme ... when they drink alcohol. Scientists from the National ... Kurihama Alcohol Center now caution that heavy alcohol consumption ... individuals, who comprise about 8 percent of the world,s ...
Cached Medicine News:Health News:New Online Network Features Continuing Education Courses for Physical Therapists 2Health News:Renowned Athlete Laila Ali and Olympic Soccer Player Tab Ramos Team With Jared Fogle to Kick Off National Pep Rally to Energize Kids to Eat Healthy and Stay Active 2Health News:Renowned Athlete Laila Ali and Olympic Soccer Player Tab Ramos Team With Jared Fogle to Kick Off National Pep Rally to Energize Kids to Eat Healthy and Stay Active 3Health News:Renowned Athlete Laila Ali and Olympic Soccer Player Tab Ramos Team With Jared Fogle to Kick Off National Pep Rally to Energize Kids to Eat Healthy and Stay Active 4Health News:South Carolina Youth Shares Epilepsy Message on Capitol Hill 2Health News:ACell and Medline Announce Exclusive Marketing and Distribution Agreement for MatriStem(TM) Proprietary Bioscaffold for Wound Care 2Health News:Arizona Youth Shares Epilepsy Message on Capitol Hill 2Health News:Alcohol 'flush' signals increased cancer risk among East Asians 2Health News:Alcohol 'flush' signals increased cancer risk among East Asians 3
... We offer a complete ... bringing laboratorians state-of-the-art monoclonal and ... the detection of enteric pathogens ... includes products for Clostridium difficile, ...
... TOX A/B QUIK CHEK test is a rapid ... B in fecal specimens. The test uses antibodies ... difficile and yields >90% sensitivity and >99% specificity ... both toxin A and toxin B, the risk ...
... autoimmune testing feature single-well ANA screen and ... reflex tests including dsDNA, and 6 individual ... (La), Scl-70 and Jo-1. In addition, our ... of products for Cardiolipins (IgA, IgG, IgM), ...
... ELISA products for autoimmune testing feature single-well ... well as specific reflex tests including dsDNA, ... SS-A (Ro), SS-B (La), Scl-70 and Jo-1. ... a full line of products for Cardiolipins ...
Medicine Products: